Developer docs
API playgroundTry for free, no card

Search company profiles

Inspirata

Full company profile

uuid0007f7n

Namestring
Inspirata
Legal namestring
Inspirata, Inc.
Websiteurl
inspirata.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Inspirata is a Tampa-headquartered, Delaware-incorporated oncology informatics company that builds AI/NLP-powered software for cancer registry automation and clinical trial matching. The company's core technology is a proprietary NLP engine refined over more than 20 years in collaboration with the National Cancer Institute and hundreds of healthcare institutions, validated through 44+ independent quality control studies demonstrating 99% sensitivity and 98% specificity on unstructured clinical document processing.

The product portfolio centers on three core offerings: E-Path (automated real-time cancer casefinding from pathology, radiology, and disease index documents, replacing 30-45 minute manual review with seconds-level processing), E-Path Plus (automated data abstraction extracting 124+ oncology-specific data elements to auto-populate NAACCR/SEER-compliant registry abstracts), and Trial Navigator (NLP-powered clinical trial matching using heuristics and statistical ranking against patient free-text medical data). Through an exclusive partnership with ONCO Inc. announced in January 2025, the company has extended into an end-to-end cancer data platform combining ONCO's OncoLog registry software and OncoNav patient navigation tool with Inspirata's AI engine, claiming the only fully integrated workflow from casefinding through submission.

Inspirata sells exclusively through enterprise field sales to large hospital systems, academic medical centers, NCI-designated cancer centers, comprehensive cancer centers, community oncology practices, and government cancer registries in the US, Canada, UK, and Australia. Pricing is quote-based SaaS subscriptions sold as multi-year enterprise contracts; the company reports 270-275+ direct hospital customers (770+ combined through ONCO), 30+ million reports processed annually, and a 96% customer retention rate. The company is privately held with no disclosed institutional investors, controlled by founder and CEO Satish K. Sanan.

Short descriptiontext

Inspirata is a private Tampa-based oncology informatics company that sells AI/NLP-powered enterprise SaaS for automated cancer casefinding, registry data abstraction, and clinical trial matching to hospitals and cancer centers in the US, Canada, UK, and Australia, with 270+ direct hospital customers and an exclusive ONCO partnership extending reach to 770+ hospitals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTampa, United States
HQ citystring
Tampa
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology informatics software, cancer registry automation, clinical NLP solutions, clinical trial matching, cancer casefinding software
Industry4 codes
1Oncology Pathways & Precision Medicine Decision Support
CodeHLACAGAHPrimaryYes
2Clinical Decision Support & Workflow Integration (EHR/oncology systems)
CodeHLAAANAEPrimaryNo
3Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
CodeHLAGAJAMPrimaryNo
4Oncology Remote Symptom Monitoring & Care Navigation
CodeHLALAFADPrimaryNo
NAICS code2 codes
  • Software Publishers513210
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Oncology Informatics Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software Subscriptions - Cancer Registry Solutions
TypeSubscription Recurring
Description

SaaS subscription model for E-Path and E-Path Plus cancer registry automation solutions, sold to hospitals, cancer centers, and healthcare systems. Pricing is quote-based and typically sold as annual or multi-year contracts to enterprise customers.

inspirata.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1E-Path
Description

Automated cancer casefinding solution that identifies reportable cancer cases in real-time with 98-99% accuracy using NLP technology.

inspirata.com
+2 more records
Core offering1 text field

Inspirata develops and sells AI/NLP-powered oncology informatics software for hospitals and cancer centers. Its core offerings include E-Path (automated cancer casefinding), E-Path Plus (automated oncology data abstraction), and Trial Navigator (AI-based clinical trial matching). Through an exclusive partnership with ONCO, the platform delivers an end-to-end cancer registry workflow from casefinding to patient navigation and reporting.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 30+ Million clinical reports processed annually across 270+ hospital customers
+5 more records
Product overview1 text field

Inspirata offers an oncology informatics platform centered on its proprietary AI/NLP engine, comprising two core product suites (E-Path for casefinding and E-Path Plus for abstraction) and Trial Navigator for clinical trial matching. Through an exclusive partnership with ONCO, the company now delivers the only end-to-end unified cancer registry solution, integrating E-Path, E-Path Plus, ONCO's OncoLog registry software, and OncoNav patient navigation into a single platform. The NLP Engine powers all products with validated 99% sensitivity across 44+ independent quality control studies.

Product and service1 record
1E-Path
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-15
Description

Strategic partnership to advance oncology data management combining ONCO's comprehensive cancer registry solutions (OncoLog) with Inspirata AI's AI/NLP technologies. Creates a unified, end-to-end cancer registry platform from casefinding to submission. Partnership aims to address workforce shortages and improve data quality through AI-powered automation.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2022-05-18
Description

Inspirata joined Advarra's API Partner Program as inaugural API Gold partner. Collaboration ensures integrations between Inspirata's Trial Navigator and Advarra's OnCore CTMS solution, providing streamlined clinical trial matching for shared customers.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2021-07-19
Description

OSF HealthCare selected Inspirata as its cancer informatics solution provider. Implementation of E-Path Plus for cancer data abstraction across the integrated health system serving nearly 3 million people throughout Illinois and Michigan with 15 hospitals.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2021-07-12
Description

Pilot evaluation of Trial Navigator software to evaluate how AI-based automation can improve identification and matching of cancer patients to early phase clinical trials. Collaboration with the Cancer Early Phase Trials Unit and ECMC Network Programme Office.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2021-07-12
Description

Pilot program evaluating Trial Navigator for AI-based clinical trial matching. Part of organization's effort to get better outcomes for cancer patients by providing opportunities to enroll in trials of new cancer drugs.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2021-06-30
Description

Multi-year, multi-million-dollar contract extension bringing E-Path Plus to VCR's network of 265 health services and 26 laboratories in Victoria, Australia. Supports ground-breaking accomplishments in shortening cancer data turnaround time and improving data accuracy.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Flatiron Health is an oncology-focused health technology company offering AI-powered EHR data abstraction and clinical trial matching, directly overlapping with Inspirata's cancer registry automation and Trial Navigator offerings.

TypeDirect peer
Description

Tempus applies AI to oncology data, including clinical trial matching and structured data extraction from unstructured clinical documents, directly competing with Inspirata's NLP engine and trial matching capabilities.

TypeDirect peer
Description

Deep 6 AI uses AI and NLP to match patients to clinical trials by mining structured and unstructured medical records, directly competing with Inspirata's Trial Navigator for clinical trial matching workflows.

TypeDirect peer
Description

Mendel.ai provides AI-powered clinical trial matching by structuring unstructured clinical data, directly comparable to Inspirata's Trial Navigator solution for oncology patient-trial matching.

TypeBroad incumbent
Description

IQVIA is a large clinical research services and technology company operating in oncology clinical trials and real-world evidence, broadly overlapping with Inspirata's clinical trial matching and oncology data analytics.

TypeDirect peer
Description

Syapse provides a precision oncology platform that integrates real-world clinical and molecular data to support cancer care decisions and clinical trial matching, comparable to Inspirata's oncology-focused informatics approach.

TypeDirect peer
Description

COTA Healthcare applies AI to oncology real-world data abstraction and analytics, overlapping with Inspirata's cancer data abstraction (E-Path Plus) and structured registry data generation.

TypeBroad incumbent
Description

Elekta is a broader oncology informatics and radiation therapy vendor that overlaps with Inspirata's cancer care workflow software, though Elekta's primary focus is radiation oncology hardware and treatment planning.

TypeBroad incumbent
Description

Varian, now part of Siemens Healthineers, provides oncology informatics, cancer registry, and clinical trial solutions as part of its broader radiation oncology portfolio, broadly overlapping with Inspirata's oncology workflow offerings.

TypeEmerging player
Description

ConcertAI provides oncology real-world data and AI-based clinical decision support, with partial overlap to Inspirata's oncology NLP engine and clinical decision support positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Inspirata

Oncology Informatics Softwareinspirata.com

Inspirata is a private Tampa-based oncology informatics company that sells AI/NLP-powered enterprise SaaS for automated cancer casefinding, registry data abstraction, and clinical trial matching to hospitals and cancer centers in the US, Canada, UK, and Australia, with 270+ direct hospital customers and an exclusive ONCO partnership extending reach to 770+ hospitals.

What Inspirata does

Inspirata is a Tampa-headquartered, Delaware-incorporated oncology informatics company that builds AI/NLP-powered software for cancer registry automation and clinical trial matching. The company's core technology is a proprietary NLP engine refined over more than 20 years in collaboration with the National Cancer Institute and hundreds of healthcare institutions, validated through 44+ independent quality control studies demonstrating 99% sensitivity and 98% specificity on unstructured clinical document processing.

The product portfolio centers on three core offerings: E-Path (automated real-time cancer casefinding from pathology, radiology, and disease index documents, replacing 30-45 minute manual review with seconds-level processing), E-Path Plus (automated data abstraction extracting 124+ oncology-specific data elements to auto-populate NAACCR/SEER-compliant registry abstracts), and Trial Navigator (NLP-powered clinical trial matching using heuristics and statistical ranking against patient free-text medical data). Through an exclusive partnership with ONCO Inc. announced in January 2025, the company has extended into an end-to-end cancer data platform combining ONCO's OncoLog registry software and OncoNav patient navigation tool with Inspirata's AI engine, claiming the only fully integrated workflow from casefinding through submission.

Inspirata sells exclusively through enterprise field sales to large hospital systems, academic medical centers, NCI-designated cancer centers, comprehensive cancer centers, community oncology practices, and government cancer registries in the US, Canada, UK, and Australia. Pricing is quote-based SaaS subscriptions sold as multi-year enterprise contracts; the company reports 270-275+ direct hospital customers (770+ combined through ONCO), 30+ million reports processed annually, and a 96% customer retention rate. The company is privately held with no disclosed institutional investors, controlled by founder and CEO Satish K. Sanan.

Inspirata firmographics

Firmographics
Name
Inspirata
Legal name
Inspirata, Inc.
Website
https://inspirata.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Inspirata is a private Tampa-based oncology informatics company that sells AI/NLP-powered enterprise SaaS for automated cancer casefinding, registry data abstraction, and clinical trial matching to hospitals and cancer centers in the US, Canada, UK, and Australia, with 270+ direct hospital customers and an exclusive ONCO partnership extending reach to 770+ hospitals.
Ownership category
akta.pro rank

Inspirata industry classification

Industry
Product category
Oncology Informatics Software
NAICS
Software Publishers (513210), Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)
akta.pro secondary industries
Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

Keywords

  • Oncology informatics software
  • Cancer registry automation
  • Clinical NLP solutions
  • Clinical trial matching
  • Cancer casefinding software

Where Inspirata is headquartered

Location

Headquarters

HQ city
Tampa
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Inspirata business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Software Subscriptions - Cancer Registry Solutions: SaaS subscription model for E-Path and E-Path Plus cancer registry automation solutions, sold to hospitals, cancer centers, and healthcare systems. Pricing is quote-based and typically sold as annual or multi-year contracts to enterprise customers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Inspirata product offering

Product offering

Core offering

Inspirata develops and sells AI/NLP-powered oncology informatics software for hospitals and cancer centers. Its core offerings include E-Path (automated cancer casefinding), E-Path Plus (automated oncology data abstraction), and Trial Navigator (AI-based clinical trial matching). Through an exclusive partnership with ONCO, the platform delivers an end-to-end cancer registry workflow from casefinding to patient navigation and reporting.

Product overview

Inspirata offers an oncology informatics platform centered on its proprietary AI/NLP engine, comprising two core product suites (E-Path for casefinding and E-Path Plus for abstraction) and Trial Navigator for clinical trial matching. Through an exclusive partnership with ONCO, the company now delivers the only end-to-end unified cancer registry solution, integrating E-Path, E-Path Plus, ONCO's OncoLog registry software, and OncoNav patient navigation into a single platform. The NLP Engine powers all products with validated 99% sensitivity across 44+ independent quality control studies.

Differentiator

Problem solved

Functional benefit

Brands

  • E-Path: Automated cancer casefinding solution that identifies reportable cancer cases in real-time with 98-99% accuracy using NLP technology.
  • E-Path Plus
  • Trial Navigator

Products and services

  • E-Path

Quantifiable outcome

  • 30+ Million clinical reports processed annually across 270+ hospital customers
  • +5 more outcomes

Companies that use Inspirata

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Inspirata technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature7 records

Inspirata partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, major and strategic.

  • ONCO Inc.coreStrategic or Co-development Partner · 15 January 2025Strategic partnership to advance oncology data management combining ONCO's comprehensive cancer registry solutions (OncoLog) with Inspirata AI's AI/NLP technologies. Creates a unified, end-to-end cancer registry platform from casefinding to submission. Partnership aims to address workforce shortages and improve data quality through AI-powered automation.
  • AdvarramajorTechnology or Integration · 18 May 2022Inspirata joined Advarra's API Partner Program as inaugural API Gold partner. Collaboration ensures integrations between Inspirata's Trial Navigator and Advarra's OnCore CTMS solution, providing streamlined clinical trial matching for shared customers.
  • OSF HealthCaremajorStrategic or Co-development Partner · 19 July 2021OSF HealthCare selected Inspirata as its cancer informatics solution provider. Implementation of E-Path Plus for cancer data abstraction across the integrated health system serving nearly 3 million people throughout Illinois and Michigan with 15 hospitals.
  • King's Health Partners ECMCstrategicStrategic or Co-development Partner · 12 July 2021Pilot evaluation of Trial Navigator software to evaluate how AI-based automation can improve identification and matching of cancer patients to early phase clinical trials. Collaboration with the Cancer Early Phase Trials Unit and ECMC Network Programme Office.
  • Guy's and St Thomas' NHS Foundation TruststrategicStrategic or Co-development Partner · 12 July 2021Pilot program evaluating Trial Navigator for AI-based clinical trial matching. Part of organization's effort to get better outcomes for cancer patients by providing opportunities to enroll in trials of new cancer drugs.
  • Victorian Cancer Registry (Cancer Council Victoria)majorStrategic or Co-development Partner · 30 June 2021Multi-year, multi-million-dollar contract extension bringing E-Path Plus to VCR's network of 265 health services and 26 laboratories in Victoria, Australia. Supports ground-breaking accomplishments in shortening cancer data turnaround time and improving data accuracy.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Inspirata competitors and assessment

Company assessment

Direct peers

  • Flatiron Health: Flatiron Health is an oncology-focused health technology company offering AI-powered EHR data abstraction and clinical trial matching, directly overlapping with Inspirata's cancer registry automation and Trial Navigator offerings.
  • Tempus Labs: Tempus applies AI to oncology data, including clinical trial matching and structured data extraction from unstructured clinical documents, directly competing with Inspirata's NLP engine and trial matching capabilities.
  • Deep 6 AI: Deep 6 AI uses AI and NLP to match patients to clinical trials by mining structured and unstructured medical records, directly competing with Inspirata's Trial Navigator for clinical trial matching workflows.
  • Mendel.ai: Mendel.ai provides AI-powered clinical trial matching by structuring unstructured clinical data, directly comparable to Inspirata's Trial Navigator solution for oncology patient-trial matching.
  • Syapse: Syapse provides a precision oncology platform that integrates real-world clinical and molecular data to support cancer care decisions and clinical trial matching, comparable to Inspirata's oncology-focused informatics approach.
  • COTA Healthcare: COTA Healthcare applies AI to oncology real-world data abstraction and analytics, overlapping with Inspirata's cancer data abstraction (E-Path Plus) and structured registry data generation.

Broad incumbents

  • IQVIA: IQVIA is a large clinical research services and technology company operating in oncology clinical trials and real-world evidence, broadly overlapping with Inspirata's clinical trial matching and oncology data analytics.
  • Elekta: Elekta is a broader oncology informatics and radiation therapy vendor that overlaps with Inspirata's cancer care workflow software, though Elekta's primary focus is radiation oncology hardware and treatment planning.
  • Varian (Siemens Healthineers): Varian, now part of Siemens Healthineers, provides oncology informatics, cancer registry, and clinical trial solutions as part of its broader radiation oncology portfolio, broadly overlapping with Inspirata's oncology workflow offerings.

Emerging players

  • Clarity Insights / ConcertAI: ConcertAI provides oncology real-world data and AI-based clinical decision support, with partial overlap to Inspirata's oncology NLP engine and clinical decision support positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Inspirata social profiles

Digital presence

Inspirata compliance and trust

Trust signal

Compliance6 records

Inspirata financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Inspirata leadership team

Management profile

Number of profiles

Profiles15 records

Inspirata subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Inspirata funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Inspirata M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inspirata

What does Inspirata do?

Inspirata develops and sells AI/NLP-powered oncology informatics software for hospitals and cancer centers. Its core offerings include E-Path (automated cancer casefinding), E-Path Plus (automated oncology data abstraction), and Trial Navigator (AI-based clinical trial matching). Through an exclusive partnership with ONCO, the platform delivers an end-to-end cancer registry workflow from casefinding to patient navigation and reporting.

Is Inspirata a public or private company?

Inspirata is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Inspirata founded?

Inspirata was founded in 2000. It employs 11 to 50 people.

Where is Inspirata based?

Inspirata is headquartered in Tampa, United States, in the North America region.

How does Inspirata make money?

One revenue line is on record: software Subscriptions - Cancer Registry Solutions.

Who are Inspirata's main competitors?

Direct peers on record are Flatiron Health, Tempus Labs, Deep 6 AI, Mendel.ai, Syapse and COTA Healthcare. Broad incumbents are IQVIA, Elekta and Varian (Siemens Healthineers). Clarity Insights / ConcertAI is listed as an emerging player.

Does Inspirata have an API?

Yes. Inspirata offers API integration capabilities through a partnership with Advarra, providing a bidirectional interface between Trial Navigator and Advarra's OnCore CTMS. The company is SOC 2 compliant and approved for the Epic App Orchard. Native API integration enables clinical trial matching workflow automation.

What industry is Inspirata in?

Inspirata's product category is Oncology Informatics Software. Its primary akta.pro industry code is HLACAGAH, Oncology Pathways & Precision Medicine Decision Support, with a secondary code of HLAAANAE, Clinical Decision Support & Workflow Integration (EHR/oncology systems). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireInspirata AI Delivers Record Q2 with Five Major Academic Cancer Centers Selecting Its Native AI PlatformInspirata AI announced a record Q2 with five academic cancer centers selecting its native AI platform for cancer registry. The partnerships span Arizona, Minnesota, Pennsylvania, and Georgia, with the platform achieving 99% accuracy in real-time casefinding. The company cites a shift toward native AI oncology platforms for measurable ROI.PR NewswireInspirata AI Unveils Rebrand Backed by Two Decades of Cancer Registry Innovation and a Deepened Partnership with ONCO Inc.Inspirata announced it has rebranded as Inspirata AI, marking a strategic shift toward enhanced AI-driven cancer casefinding, data abstraction, and reporting capabilities. The rebrand reflects a strengthened partnership with ONCO Inc., offering healthcare organizations an end-to-end cancer registry solution with claimed 99% accuracy across the United States, Canada, and Australia.KMS Technology8 Use Cases for Natural Language Processing in HealthcareThe global market for Natural Language Processing (NLP) in healthcare is projected to reach $3.7 billion by 2025, driven by a 20.5% compound annual growth rate as organizations seek to unlock insights from unstructured electronic health records. NLP technologies are being deployed across eight key use cases, including clinical documentation automation, speech recognition, and clinical trial matching, to enhance patient care and operational efficiency. Companies such as IBM Watson Health, Inspirata, Nuance, and KMS Technology are actively developing or implementing these solutions to transform healthcare data management.PauboxNatural language processing in healthcareAn explainer article outlines how natural language processing is applied in healthcare, covering clinical documentation, medical coding, clinical trial recruitment, patient sentiment analysis, and drug discovery. It cites tools such as Nuance's Dragon Medical One, 3M's 360 Encompass System, Inspirata and Lymba, and notes challenges including medical jargon, bias and explainability.Imaging Technology NewsDevelop, Partner, Acquire or Avoid: Where is Investment for Digital Pathology Headed?Fujifilm acquired Inspirata's digital pathology assets in December, following industry debate. VC investment has slowed since 2021, with no recent rounds comparable to PathAI or Paige.ai's $100M rounds. The market remains ripe, with potential acquisitions expected in 2023.GlobeNewswireFujifilm Completes Asset Purchase Agreement of Inspirata, Inc.’s Digital Pathology BusinessFujifilm completed its asset purchase of Inspirata's digital pathology business on January 23, 2023, bringing Dynamyx technology and U.S. employees under FUJIFILM Healthcare Americas. The company also established a pathology division led by Dr. Mark Lloyd to expand its Synapse Enterprise Imaging portfolio. The integrated technologies will be demonstrated at USCAP and HIMSS meetings in March and April.GlobeNewswireHealthcare Technology Leader Laure Tessier-Delivuk Joins Inspirata as Vice President of Operations for Oncology InformaticsLaure Tessier-Delivuk joined Inspirata as Vice President of Operations for Oncology Informatics on November 17, 2022. She brings over 25 years of healthcare technology leadership, including a senior role at GE Healthcare Digital. She will manage the Oncology Informatics business unit across engineering, product, and support teams.GlobeNewswireInspirata Unveils New Partnership at the Association of Pathology Chairs (APC) Annual Meeting 2022Inspirata announced a partnership with SpIntellx at the APC Annual Meeting in Chicago, integrating Dynamyx and HistoMapr-Breast for breast core-biopsy workflows. The integration provides spatial analytics powered by explainable AI, and Inspirata will showcase Dynamyx release 2.5.0 at the event.GlobeNewswireInspirata Joins Advarra’s New API Partner Program as an Inaugural MemberInspirata joined Advarra's Partner Program as an inaugural API Gold partner, enabling out-of-the-box integrations between OnCore and Trial Navigator. The partnership aims to improve performance and reduce implementation burden for shared customers. It aligns with both companies' focus on streamlined customer experiences.PR NewswireGlobal Precision Medicine Software Developers Market Research Report 2021-2031 with Profiles of Ariel Precision Medicine, C2i Genomics, Genedata, Inspirata,. IQVIA & SAPResearch and Markets has published a comprehensive market research report detailing the global precision medicine software developers landscape from 2021 to 2031. The study provides extensive profiles of key industry players, including Ariel Precision Medicine, C2i Genomics, Genedata, Inspirata, IQVIA, and SAP, alongside analysis of patents, partnerships, and funding trends.